Legacy Wealth Asset Management, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1846151 WOODBURY, MN

Position in ALNY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$219,450

-$28,040 QoQ

Shares Held

729

-2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#32

of 61 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Legacy Wealth Asset Management, LLC holds $4,063,533 across 4 Biotechnology names. ALNY ranks #4 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GMAB	Genmab A/S	102,164	$2,806,445
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,496	$743,108
3	HALO	Halozyme Therapeutics, Inc.	3,763	$294,530
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	729	$219,450

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$219,450	729	-2.5%	Shares	Sole	2026-07-09
2026-03-31	$247,490	748	+12.0%	Shares	Sole	2026-04-08
2025-12-31	$265,630	668	-3.7%	Shares	Sole	2026-01-12
2025-09-30	$316,464	694	—	Shares	Sole	2025-10-14
No filing history on record for this holder in this stock.